Jiangsu Favored Nanotechnology Co., Ltd

XSSC:688371 Voorraadrapport

Marktkapitalisatie: CN¥5.0b

Jiangsu Favored Nanotechnology Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Jiangsu Favored Nanotechnology has a total shareholder equity of CN¥1.9B and total debt of CN¥3.3M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are CN¥2.0B and CN¥122.1M respectively. Jiangsu Favored Nanotechnology's EBIT is CN¥8.9M making its interest coverage ratio -0.9. It has cash and short-term investments of CN¥722.7M.

Belangrijke informatie

0.2%

Verhouding schuld/eigen vermogen

CN¥3.27m

Schuld

Rente dekkingsratio-0.9x
ContantCN¥722.66m
AandelenCN¥1.90b
Totaal verplichtingenCN¥122.14m
Totaal activaCN¥2.02b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 688371's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥119.7M).

Langlopende schulden: 688371's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥2.4M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 688371 has more cash than its total debt.

Schuld verminderen: 688371's debt to equity ratio has reduced from 7.8% to 0.2% over the past 5 years.

Schuldendekking: 688371's debt is well covered by operating cash flow (2055.6%).

Rentedekking: 688371 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven